mySugr

Vienna, Austria Founded: 2012 • Age: 14 yrs Acquired By Roche
Gamified apps for diabetes management and therapy are provided.

About mySugr

mySugr is a Healthcare company based in Vienna (Austria) founded in 2012, and was acquired by Roche in June 2017. Gamified apps for diabetes management and therapy are provided. It operates on a Freemium and HealthTech model in Healthcare and Technology sectors. mySugr has raised $4.8 million across 2 funding rounds from investors including Roche, Gotthardt Healthgroup and iSeed Ventures. Its website mysugr.com draws about 143 thousand monthly visits. mySugr offers products and services including mySugr App, mySugr Bolus Calculator, and mySugr Pump Control. Its focus areas include Digital Health and Diabetes Management. Its legal entity is mySugr GmbH.

Company details

mySugr is dedicated to easing the daily challenges of diabetes management. The company offers a digital health app designed for people with diabetes, created by individuals with diabetes. Solutions include personalized logging, blood glucose meter connectivity, bolus calculators, and pump control features. Since joining the Roche family in 2017, mySugr has expanded its reach to support individuals with diabetes and other chronic conditions globally. The app integrates with devices like Accu-Chek meters and provides secure data handling under GDPR standards. It operates in the healthcare sector, specifically targeting digital health and diabetes care.

  • Headquarters Vienna, Austria
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mysugr.com/en-us
  • Social LinkedIn X Facebook
  • Acquired by Roche (Jun 2017)
  • Legal Name Mysugr Gmbh
Key Metrics
  • Total Equity Funding
    $4.8M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.8M (USD), Seed

    Mar 2015

  • Investors
    Roche

    & 4 more

  • Acquired by
    Roche

    (Jun 2017)

Products & Services of mySugr

mySugr offers a comprehensive portfolio of products and services, including mySugr App, mySugr Bolus Calculator, and mySugr Pump Control.

mySugr App
Digital Health

Diabetes management app for tracking and logging data.

mySugr Bolus Calculator
Medical Device

Tool for calculating insulin doses for meals accurately.

mySugr Pump Control
Medical Device

Feature for controlling insulin pumps via app interface.

Apps and channels of mySugr

mySugr publishes 2 mobile apps with over 5M+ downloads.

mySugr - Diabetes Tracker Log
Google Play Medical Everyone Free
Developer: mySugr GmbH
View on Google Play
mySugr - Diabetes Tracker Log
App Store Medical 4+
Developer: mySugr GmbH
View on App Store

Funding Insights of mySugr

mySugr has successfully raised a total of $4.8M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.8 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.8M
  • Total Rounds 2
  • Last Round Seed β€” $4.8M
  • Investors Count 4

All 2 funding rounds of mySugr with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2015$4.8MSeed–iSeed Ventures, Roche
Jan 2012Angel Round––
–
Valuation history

5 investors in total: 4 institutional and 1 angel.

Investors in mySugr

mySugr has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Roche, Gotthardt Healthgroup and iSeed Ventures.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in AI and digital health startups based in San Francisco.
iseedvc.com
Corporate-backed venture capital firm focused on the healthcare sector
roche.com/venturefund.htm
Software solutions for clinical trials are developed by Gotthardt Healthgroup.
2015gotthardt.comHeidelberg, Germany
Pharmaceuticals and diagnostics kits are developed for various diseases.
1896roche.comBasel, Switzerland

Hansi Hansmann

unknown_53cf9f85e2874f31a
Premium access

Investor details for mySugr

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of mySugr

6 people are tracked at mySugr (5 in leadership, 1 in team).

NameRoleGroup
Stephan Silbermann
Medical DirectorLeadership
Elisabeth Kölbel
Managing DirectorLeadership
Daniel Getta
Head of FinanceLeadership
Birgit Richter
Managing Director, Trade Law & Head of Regulatory AffairsLeadership
Nilo Paredes
Global Head of Digital EngineeringLeadership
Pascal Hofer
Legal CounselTeam
Premium access

Complete people profiles for mySugr

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of mySugr

4 dated milestones of mySugr across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded mySugr is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed, of $4.8M.
  4. Exit Acquired by Roche.

Web traffic of mySugr

The website of mySugr (mysugr.com) receives about 143.2K visits a month.

  • Monthly visits
    143.2K

    ▼ 8.3% vs previous month

Similar websites

Websites whose visitors overlap most with mySugr. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
diabetes.ufl.edu
diabetes.ufl.edu
100%
–
diabetesde.org
diabetesde.org
86%
#520,766–
diabetes-kids.de
84%
#1,970,273View details
diabetesforecast.org
diabetesforecast.org
78%
–
diabetesvic.org.au
diabetesvic.org.au
78%
#1,158,605–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for mySugr

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mysugr

Premium access

Complete news archive for mySugr

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about mySugr

mySugr was founded in 2012.

mySugr is headquartered in Vienna, Austria.

mySugr is a funded company, having raised a total of $4.8M across 2 funding rounds to date.

mySugr is dedicated to easing the daily challenges of diabetes management. The company offers a digital health app designed for people with diabetes, created by individuals with diabetes. Solutions include personalized logging, blood glucose meter connectivity, bolus calculators, and pump control features. Since joining the Roche family in 2017, mySugr has expanded its reach to support individuals with diabetes and other chronic conditions globally. The app integrates with devices like Accu-Chek meters and provides secure data handling under GDPR standards. It operates in the healthcare sector, specifically targeting digital health and diabetes care.

mySugr offers mySugr App, mySugr Bolus Calculator, and mySugr Pump Control.

mySugr has 5 investors. Key investors include Roche, Gotthardt Healthgroup, iSeed Ventures, Roche, and Hansi Hansmann.

mySugr operates through Mysugr Gmbh.

Yes. mySugr was acquired by Roche in June 2017.

Yes. mySugr publishes mySugr - Diabetes Tracker Log and 1 more app, with over 5 million downloads.

The website of mySugr receives about 143 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available